Titlebook: Small Molecules in Hematology; Uwe M. Martens Book 2018Latest edition Springer International Publishing AG, part of Springer Nature 2018 S

整洁

Book 2018Latest edition of cancer cells can be attacked by small molecules such as protein tyrosine kinase inhibitors. An accompanying volume addresses the use of small molecules in oncology, and the two volumes together represent the third edition of the book originally published under the same title. .

压碎

978-3-030-08256-7Springer International Publishing AG, part of Springer Nature 2018

欢呼

一加就喷出

Recent Results in Cancer Researchhttp://image.papertrans.cn/s/image/868497.jpg

thrombus

https://doi.org/10.1007/978-3-319-91439-8Small Molecules; Molecular Mechanisms of Cancer; Targeted Therapy; Personalized Cancer Therapy; Protein

Nonthreatening

dendrites

Nilotinib,line treatment of chronic-phase chronic myeloid leukemia. By reaching deep and long-lasting molecular remissions, discontinuation of TKIs is becoming one of the central topics of future CML therapy. Stopping nilotinib seems safe and provides a stable remission in about half of the eligible patients, though long-term data are still missing.

Cabg318

不爱防注射

0080-0015 tion, drug targets, and drug interactions.Examines preclinic.This book, written by respected experts, discusses in detail the latest developments in targeted therapy for hematologic malignancies using small molecules. It covers a wide range of small molecules including tyrosine kinase inhibitors, im

臭了生气